HomeCoronary diseaseDrug-eluting stents

Drug-eluting stents

Left Main Coronary Artery PCI Using State-of-the-Art Zotarolimus-Eluting Stents

Percutaneous coronary intervention (PCI) to the left main coronary artery (LMCA) with drug-eluting stent implantation is currently...

Trans-Stent Gradient as a Predictor of Adverse Events at Followup

Stenting a coronary lesion should not present a drop in pressure when measuring the treated segment with...

The New Sirolimus Eluting Balloons Are Also Effective

The technological development of drug eluting stents has allowed us to treat increasingly complex patients, with around...

Should We Start Using Ultra-Thin Struts?

The benefits of DES are well known, as well as the benefits of more recent polymer-based DES...

Is TCA Useful for Severe Impairment of Left Ventricular Ejection Fraction?

Heart disease is the most frequent cause of heart failure and, in some observational studies, transluminal coronary...

ESC 2022 | Should We Follow-Up with Functional Testing in High-Risk Patients after CTA?

While the need for repeat cinecoronary angiography after transluminal coronary angioplasty (TCA) has decreased with the use...

Longitudinal Deformation of a Stent with the POT Technique

The fractal geometry of coronary bifurcations offers a mismatch between the proximal diameter of the main branch...

Thin vs. Ultrathin Stents: 1-Year Clinical Results After IVUS/OCT-Guided Implantation

Second generation drug-eluting stents have lower frequency of thrombotic complications and in-stent restenosis. While clinical results have...